IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Merck KGaA Confirms Generics Sale; Launches Merck Serono

2:35 PM MDT | July 18, 2007 | Alex Scott

Merck KGaA has confirmed that it is “evaluating the divestiture” of its Merck Generics generic drug division (CW, Jan. 3/10, p. 5). The company says it is in the early stages of planning to sell the generics business, and that it is “not engaged in initial discussions with any potential buyers.” Analysts say that the sale of the generics business could raise up to €4 billion ($5.3 billion). Private equity firms, rather than pharma manufacturers, are more likely to be interested in buying Merck Generics, analysts add. Ranbaxy, one of...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa